Darifenacin D4 hydrochloride
| Product Name | Darifenacin D4 hydrochloride |
|---|---|
| Alternate Names | Darifenacin Stable Isotopes, Stable Isotopes of Darifenacin |
| CAT No. | CS-O-03226 |
| CAS No. | 1095598-84-7 (Freebase) |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 467.04 g/mol |
| Mol. For. | C₂₈H₂₇D₄ClN₂O₂ |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Darifenacin |
| Purity | 99.28 |
| Smileys | O=C(N)C(C1=CC=CC=C1)([C@H]2CN(C([2H])([2H])C([2H])([2H])C3=CC=C(OCC4)C4=C3)CC2)C5=CC=CC=C5.[H]Cl |
| Canonical Smiles | C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5.Br |
| InchIKey | UQAVIASOPREUIT-VQIWEWKSSA-N |
| Inchl | InChI=1S/C28H30N2O2.BrH/c29-27(31)28(23-7-3-1-4-8-23,24-9-5-2-6-10-24)25-14-17-30(20-25)16-13-21-11-12-26-22(19-21)15-18-32-26;/h1-12,19,25H,13-18,20H2,(H2,29,31);1H/t25-;/m1./s1 |
| IUPAC | 2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide;hydrobromide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Darifenacin D4 hydrochloride is a medication that is used to treat overactive bladder (OAB) symptoms such as urinary urgency, frequency, and incontinence. It is a selective M3 muscarinic receptor antagonist that works by blocking the neurotransmitter acetylcholine from binding to the M3 receptors in the bladder, leading to a decrease in bladder contractions and an increase in bladder capacity.
Chemically, Darifenacin D4 hydrochloride is a deuterated form of Darifenacin hydrochloride, which means that it contains four deuterium atoms instead of hydrogen atoms. Deuterium is a non-radioactive isotope of hydrogen that can be used in drug development to improve pharmacokinetic properties such as bioavailability and metabolic stability.
The recommended dosage of Darifenacin D4 hydrochloride is 7.5 mg once daily, and it is available in tablet form for oral administration. The medication should be taken with water and swallowed whole, and it should not be crushed or chewed.
Like all medications, Darifenacin D4 hydrochloride may cause side effects such as dry mouth, constipation, blurred vision, and urinary retention. It may also interact with other medications such as ketoconazole, erythromycin, and rifampin.
In conclusion, Darifenacin D4 hydrochloride is a selective M3 muscarinic receptor antagonist used to treat overactive bladder symptoms. It is chemically similar to Darifenacin hydrochloride but contains deuterium atoms, and it should be taken as directed by a healthcare provider.
Get an Instant Quote
Related Compounds
rac Darifenacin-d4 | Darifenacin D4 Hydrobromide | Darifenacin D4 |